Gainers

• $Focus Universal(FCUV.US)$ rose 39.7% to $26.93 in pre-market trading after jumping 278% on Wednesday. Focus Universal recently priced 2 million shares at $5 per share to raise $10 million for its initial public offering on the Nasdaq.

• $Tiziana Life Sciences PLC(TLSA.US)$ shares rose 24.2% to $2.05 in pre-market trading. Precision BioSciences and Tiziana Life Sciences reported an exclusive license agreement to evaluate foralumab, a novel, fully human anti-CD3 monoclonal antibody, in conjunction with allogeneic CAR T candidates for cancer treatment.

• $Zosano Pharma Corp(ZSAN.US)$ rose 17% to $0.8242 in pre-market trading. The company, last month, posted a loss for the second quarter.

• $Support.com(SPRT.US)$ shares rose 12.2% to $27.05 in pre-market trading. Support.com shares dropped over 23% on Wednesday on continued volatility as the stock has been circulated as a short squeeze name.

• $ChargePoint Holdings(CHPT.US)$ rose 11.4% to $23.64 in pre-market trading after the company reported upbeat Q2 sales and raised FY22 sales guidance.

• $Intercure(INCR.US)$ shares rose 11.4% to $7.52 in pre-market trading after declining 5% on Wednesday.

• $Asana(ASAN.US)$ rose 9.6% to $84.69 in pre-market trading after the company reported upbeat Q2 earnings results and issued guidance. The company also announced the appointment of Anne Raimondi as Chief Operating Officer.

• $INmune Bio Inc(INMB.US)$ shares rose 9.5% to $26.16 in pre-market trading after the company announced XPro has been found to decrease multiple species of Phospho Tau and improve neuroimaging biomarkers of myelination in patients with AD.

• $Ferroglobe PLC(GSM.US)$ rose 9% to $9.90 in pre-market trading after gaining over 9% on Wednesday.

• $Innate Pharma SA(IPHA.US)$ rose 7.7% to $3.90 in pre-market trading. Innate Pharma said two oral presentations will be highlighted at the ESMO 2021 Virtual Congress.

Losers

• $Meten EdtechX Education(METX.US)$ shares fell 50.5% to $0.455 in pre-market trading after the company priced its 200 million share offering at $0.30 per share.

• $Assembly Biosciences Inc(ASMB.US)$ fell 20.7% to $3.09 in pre-market trading after the company announced the decision to discontinue clinical development of ABI-H2158.

• $ABVC BioPharma(ABVC.US)$ shares fell 10.6% to $3.21 in pre-market trading. ABVC BioPharma shares jumped around 24% on Wednesday after the company announced new PCT filings for MDD and ADHD treatments.

• $Hall Of Fame Resort & Entertainment(HOFV.US)$ shares fell 10.2% to $3.01 in pre-market trading. Hall of Fame Resort & Entertainment postponed its Highway 77 Music Festival.

• $Chewy(CHWY.US)$ fell 9.8% to $78.86 in pre-market trading after the company reported worse-than-expected Q2 sales results.

• $Five Below Inc(FIVE.US)$ fell 8.8% to $197.10 in pre-market trading. Five Below reported upbeat earnings for its second quarter, while sales missed expectations. The company also said it sees Q3 earnings of $0.23 to $0.30 per share on sales of $550 million to $565 million.

• $Evaxion Biotech A/S(EVAX.US)$ fell 8.6% to $7.11 in pre-market trading after jumping 19% on Wednesday.

• $Veeva Systems Inc(VEEV.US)$ fell 8.3% to $306.02 in pre-market trading r after the company announced Q2 earnings results and issued guidance.

• $C3.ai(AI.US)$ shares fell 8% to $48.85 in pre-market trading after the company reported worse-than-expected Q1 earnings. The company also issued Q2 and FY22 guidance.

• $Sequential Brands Group Inc(SQBG.US)$ fell 7% to $7.31 in pre-market trading after jumping 53% on Wednesday. The company on Tuesday announced it commenced voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware.